How much funding has LYMPHAXIS, INC. raised?

LYMPHAXIS, INC. has raised $1.9M in total funding, most recently a Grant round.

Who are LYMPHAXIS, INC.'s investors?

LYMPHAXIS, INC.'s investors include Department of Health and Human Services.

When was LYMPHAXIS, INC. founded?

LYMPHAXIS, INC. was founded in 2023.

Where is LYMPHAXIS, INC. headquartered?

LYMPHAXIS, INC. is headquartered in Mountain View, California, United States.

What industry is LYMPHAXIS, INC. in?

LYMPHAXIS, INC. operates in Healthcare, Biotech.

LYMPHAXIS, INC.

Mountain View, United States · Founded 2023 · $1.9M raised

Healthcare

Biotech

Headquarters: Mountain View, California
Founded: 2023
Business Model: B2G

Total Funding: $1.9M
Last Round: $1.9M GrantSep 2016
Rounds: 1

About

LymphAxis, Inc. is an early-stage medical device company developing a minimally invasive system that taps directly into the lymphatic system via the thoracic duct to enable lymphocyte isolation for CAR-T cell harvesting and other cellular therapy applications. The company received NIH SBIR funding and participated in NIH's Technical and Business Assistance (TABA) program to support its commercialization pathway. Its primary customers are academic medical centers and CAR-T production companies engaged in adoptive cell therapy procedures. LymphAxis is differentiated by its novel access approach to the lymphatic system, which bypasses the need for traditional leukapheresis for immune cell collection.

Summary

LYMPHAXIS, INC. is a Healthcare company based in Mountain View, United States, founded in 2023. It has raised $1.9M in total across 1 round, most recently a $1.9M Grant round in Sep 2016. Investors include Department of Health and Human Services.